A detailed history of Plato Investment Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Plato Investment Management LTD holds 44,510 shares of ABT stock, worth $5.24 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
44,510
Previous 44,510 -0.0%
Holding current value
$5.24 Million
Previous $4.63 Billion 9.61%
% of portfolio
0.41%
Previous 0.43%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $300,880 - $335,858
2,987 Added 7.19%
44,510 $4.63 Billion
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $4.24 Million - $4.68 Million
38,680 Added 1360.53%
41,523 $7.23 Billion
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $256,410 - $313,867
2,843 New
2,843 $313 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.